Literature DB >> 16886281

BRCA2 mutation and the risk of hematologic malignancy.

Michael J Hall, Loretta Li, Peter H Wiernik, Olufunmilayo I Olopade.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16886281

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

1.  Acute promyelocytic leukemia in a young patient with breast cancer.

Authors:  Ozgur Kara; Evren Ozdemir; Cagatay Arslan; Erkan Dogan; Kadri Altundag
Journal:  Med Oncol       Date:  2010-02-06       Impact factor: 3.064

2.  BRCA2-associated therapy-related acute myeloid leukemia.

Authors:  Armin Rashidi; Ina Amarillo; Stephen I Fisher
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

3.  Occurrence of BCR/ABL fusion gene in a patient with acute promyelocytic leukemia.

Authors:  Li-Juan Zhang; Yi-Min Gan; Liang Yu
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

Review 4.  Therapy-related acute promyelocytic leukemia: a systematic review.

Authors:  Armin Rashidi; Stephen I Fisher
Journal:  Med Oncol       Date:  2013-06-15       Impact factor: 3.064

5.  Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia.

Authors:  Jane E Churpek; Rafael Marquez; Barbara Neistadt; Kimberly Claussen; Ming K Lee; Matthew M Churpek; Dezheng Huo; Howard Weiner; Mekhala Bannerjee; Lucy A Godley; Michelle M Le Beau; Colin C Pritchard; Tom Walsh; Mary-Claire King; Olufunmilayo I Olopade; Richard A Larson
Journal:  Cancer       Date:  2015-12-07       Impact factor: 6.860

6.  The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study.

Authors:  Javaid Iqbal; Andre Nussenzweig; Jan Lubinski; Tomasz Byrski; Andrea Eisen; Louise Bordeleau; Nadine M Tung; Siranoush Manoukian; Catherine M Phelan; Ping Sun; Steven A Narod
Journal:  Br J Cancer       Date:  2016-03-17       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.